Oncimmune Overview

  • Founded
  • 2002
Founded
  • Status
  • Public
  • Employees
  • 66
Employees
  • Stock Symbol
  • ONC
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $1.68
  • (As of Thursday Closing)

Oncimmune General Information

Description

Oncimmune Holdings PLC is engaged in diagnosing cancer. It is involved in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Other Healthcare Technology Systems
Other Industries
Laboratory Services (Healthcare)
Stock Exchange
LON
Primary Office
  • MediCity - D6 Building
  • 1 Thane Road
  • Nottingham NG90 6BH
  • England, United Kingdom
+44 0115 000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Oncimmune Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.68 $1.71 $0.39 - $1.75 $107M 63.5M 225K -$0.20

Oncimmune Financials Summary

In Thousands,
USD
TTM 30-Nov-2019 FY 2019 31-May-2019 FY 2018 31-May-2018 FY 2017 31-May-2017
EV 34,480 62,204 95,363 83,480
Revenue 455 222 322 275
EBITDA (12,956) (10,848) (8,309) (6,626)
Net Income (12,762) (10,409) (8,507) (6,423)
Total Assets 16,530 11,891 19,142 8,206
Total Debt 11,090 0 0 643
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Oncimmune Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Oncimmune‘s full profile, request access.

Request a free trial

Oncimmune Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Oncimmune Holdings PLC is engaged in diagnosing cancer. It is involved in the development, manufacture and commercialisa
Other Healthcare Technology Systems
Nottingham, United Kingdom
66 As of 2019
00000
000000000 00000

0-00-000

nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
00000 0000000000 0000000000 0000000
Concord, MA
00 As of 0000
000.00
000000&0 000.00

000000 0

ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor i
0000000000 00000000 (0000000000)
Rutherford, NJ
000 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Oncimmune Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
N-of-One Formerly VC-backed Concord, MA 00 000.00 000000&0 000.00
000000 00000000 Formerly VC-backed Rutherford, NJ 000 000.00 00000000000 000.00
0000 00000 0000000 Formerly VC-backed Cambridge, MA 000 000.00 000000&0 000.00
0000000 Formerly VC-backed San Francisco, CA 0000 00000 000000000 00000
0000000 0000 Venture Capital-Backed Sunnyvale, CA 00 0000 000000 00 0000
To view Oncimmune’s complete competitors history, request access »

Oncimmune Executive Team (10)

Name Title Board Seat Contact Info
Adam Hill Ph.D Chief Executive Officer & Board Member
Matthew Hall Chief Financial Officer, Finance & Board Member
Andre Murray Ph.D Chief Operational Scientist
James Jett Chief Medical Officer
You’re viewing 4 of 10 executive team members. Get the full list »

Oncimmune Board Members (13)

Name Representing Role Since
0000 0000 00.0 Oncimmune Chief Executive Officer & Board Member 000 0000
000000 00000 Oncimmune Board Member 000 0000
00000000 0000000 Self Board Member 000 0000
0000000 0000 Oncimmune Chief Financial Officer, Finance & Board Member 000 0000
00000000 0000000 Oncimmune Chairman & Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Oncimmune Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oncimmune Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Oncimmune‘s full profile, request access.

Request a free trial

Oncimmune Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000000 19-Mar-2019 000000000000000000 00.000 Diagnostic Equipment 0000 0000 00.0
Central Medical Laboratory 24-Sep-2015 Merger/Acquisition Other Healthcare Services
To view Oncimmune’s complete acquisitions history, request access »

Oncimmune Subsidiaries (1)

Company Name Industry Location Founded
00000000 000000000 Diagnostic Equipment Dortmund, Germany 0000
To view Oncimmune’s complete subsidiaries history, request access »